160 related articles for article (PubMed ID: 26110232)
21. PMS2 germline mutation c.943C>T (p.Arg315*)-induced Lynch syndrome-associated ovarian cancer.
Guo X; Wu W; Gao H; Li X; He Q; Zhu Y; Liu N
Mol Genet Genomic Med; 2019 Jun; 7(6):e721. PubMed ID: 31056861
[TBL] [Abstract][Full Text] [Related]
22. MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer.
Roberts ME; Jackson SA; Susswein LR; Zeinomar N; Ma X; Marshall ML; Stettner AR; Milewski B; Xu Z; Solomon BD; Terry MB; Hruska KS; Klein RT; Chung WK
Genet Med; 2018 Oct; 20(10):1167-1174. PubMed ID: 29345684
[TBL] [Abstract][Full Text] [Related]
23. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations.
Yılmaz A; Mirili C; Bilici M; Tekin SB
Int J Colorectal Dis; 2020 Feb; 35(2):351-353. PubMed ID: 31845022
[TBL] [Abstract][Full Text] [Related]
25. The Apparent Genetic Anticipation in PMS2-Associated Lynch Syndrome Families Is Explained by Birth-cohort Effect.
Ten Broeke SW; Rodríguez-Girondo M; Suerink M; Aretz S; Bernstein I; Capellá G; Engel C; Gomez-Garcia EB; van Hest LP; von Knebel Doeberitz M; Lagerstedt-Robinson K; Letteboer TGW; Moller P; van Os TA; Pineda M; Rahner N; Olderode-Berends MJW; von Salomé J; Schackert HK; Spruijt L; Steinke-Lange V; Wagner A; Tops CMJ; Nielsen M
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1010-1014. PubMed ID: 30824524
[TBL] [Abstract][Full Text] [Related]
26. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers.
Win AK; Dowty JG; Antill YC; English DR; Baron JA; Young JP; Giles GG; Southey MC; Winship I; Lipton L; Parry S; Thibodeau SN; Haile RW; Gallinger S; Le Marchand L; Lindor NM; Newcomb PA; Hopper JL; Jenkins MA
Obstet Gynecol; 2011 Apr; 117(4):899-905. PubMed ID: 21422863
[TBL] [Abstract][Full Text] [Related]
27. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
Win AK; Lindor NM; Winship I; Tucker KM; Buchanan DD; Young JP; Rosty C; Leggett B; Giles GG; Goldblatt J; Macrae FA; Parry S; Kalady MF; Baron JA; Ahnen DJ; Marchand LL; Gallinger S; Haile RW; Newcomb PA; Hopper JL; Jenkins MA
J Natl Cancer Inst; 2013 Feb; 105(4):274-9. PubMed ID: 23385444
[TBL] [Abstract][Full Text] [Related]
28. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.
Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621
[TBL] [Abstract][Full Text] [Related]
29. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
30. An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome.
Suerink M; Rodríguez-Girondo M; van der Klift HM; Colas C; Brugieres L; Lavoine N; Jongmans M; Munar GC; Evans DG; Farrell MP; Genuardi M; Goldberg Y; Gomez-Garcia E; Heinimann K; Hoell JI; Aretz S; Jasperson KW; Kedar I; Modi MB; Nikolaev S; van Os TAM; Ripperger T; Rueda D; Senter L; Sjursen W; Sunde L; Therkildsen C; Tibiletti MG; Trainer AH; Vos YJ; Wagner A; Winship I; Wimmer K; Zimmermann SY; Vasen HF; van Asperen CJ; Houwing-Duistermaat JJ; Ten Broeke SW; Nielsen M
Genet Med; 2019 Dec; 21(12):2706-2712. PubMed ID: 31204389
[TBL] [Abstract][Full Text] [Related]
31. The changing landscape of Lynch syndrome due to PMS2 mutations.
Blount J; Prakash A
Clin Genet; 2018 Jul; 94(1):61-69. PubMed ID: 29286535
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of proximal colectomy for surgical management of right-sided first colorectal cancer in Lynch Syndrome mutation carriers.
Hiatt MJ; Casey MJ; Lynch HT; Snyder CL; Stacey M; Walters RW
Am J Surg; 2018 Jul; 216(1):99-105. PubMed ID: 29153248
[TBL] [Abstract][Full Text] [Related]
33. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.
Ait Ouakrim D; Dashti SG; Chau R; Buchanan DD; Clendenning M; Rosty C; Winship IM; Young JP; Giles GG; Leggett B; Macrae FA; Ahnen DJ; Casey G; Gallinger S; Haile RW; Le Marchand L; Thibodeau SN; Lindor NM; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26109217
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.
de Jong AE; van Puijenbroek M; Hendriks Y; Tops C; Wijnen J; Ausems MG; Meijers-Heijboer H; Wagner A; van Os TA; Bröcker-Vriends AH; Vasen HF; Morreau H
Clin Cancer Res; 2004 Feb; 10(3):972-80. PubMed ID: 14871975
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.
Haraldsdottir S; Rafnar T; Frankel WL; Einarsdottir S; Sigurdsson A; Hampel H; Snaebjornsson P; Masson G; Weng D; Arngrimsson R; Kehr B; Yilmaz A; Haraldsson S; Sulem P; Stefansson T; Shields PG; Sigurdsson F; Bekaii-Saab T; Moller PH; Steinarsdottir M; Alexiusdottir K; Hitchins M; Pritchard CC; de la Chapelle A; Jonasson JG; Goldberg RM; Stefansson K
Nat Commun; 2017 May; 8():14755. PubMed ID: 28466842
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
[TBL] [Abstract][Full Text] [Related]
37. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of the PREMM
Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S
J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and structural characterization of two variants of uncertain significance in the PMS2 gene.
D'Arcy BM; Blount J; Prakash A
Hum Mutat; 2019 Apr; 40(4):458-471. PubMed ID: 30653781
[TBL] [Abstract][Full Text] [Related]
40. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
